UBS Raises Price Target on Ralph Lauren (RL) to $117; Reiterates Buy

Go back to UBS Raises Price Target on Ralph Lauren (RL) to $117; Reiterates Buy

Ralph Lauren (RL): Raising PT But Acknowledge Lack of Visibility Beyond '17

August 11, 2016 6:23 AM EDT

Cowen analyst, John Kernan, reiterated his Market Perform rating on Ralph Lauren (NYSE: RL) after the company reported non-GAAP EPS of $1.06 vs. consensus of $0.89. The analyst notes that the results excluded $159MM of restructuring charges. Guidance for 2H implies mid-teen revenue declines as... More

Pre-Open Stock Movers 08/10: (CLNE) (OCN) (HRTX) (YELP) Higher; (GEVO) (SPWR) (MYGN) (PRGO) Lower (more...)

August 10, 2016 9:28 AM EDT

Today's Pre-Open Stock Movers

Gevo (NASDAQ: GEVO) 30% LOWER; reported Q2 EPS of ($0.15), versus ($0.66) reported last year. Revenue for the quarter came in at $8.11 million, versus $8.9 million reported last year.

SunPower (NASDAQ: SPWR) 30% LOWER; reported Q2 EPS of ($0.22), $0.02 better than the analyst estimate of ($0.24). Revenue for the quarter came in at $420.5 million versus the consensus estimate of $345.08 million. GUIDANCE:... More

Ralph Lauren (RL) Tops Q1 EPS by 17c, Offers Outlook

August 10, 2016 8:05 AM EDT

Ralph Lauren (NYSE: RL) reported Q1 EPS of $1.06, $0.17 better than the analyst estimate of $0.89. Revenue for the quarter came in at $1.55 billion versus the consensus estimate of $1.53 billion.

Consolidated comparable store sales decreased 6% on a reported basis and 7% in constant currency during the first quarter, primarily due to lower traffic trends.

Second Quarter and Full Year Fiscal 2017 Outlook

In the second quarter of Fiscal 2017, the Company... More

Trading Radar for 8/10: Wendy's (WEN), Michael Kors (KORS), Shake Shack (SHAK), Ralph Lauren (RL) Report

August 9, 2016 3:20 PM EDT

The Trading Radar highlights key earnings and economic announcements for the next trading session:

Before Markets Open:
Earnings:

Abraxas Petroleum (NYSE: AXAS) - no Street consensus
AdvancePierre Foods Holdings, Inc. (Nasdaq: APFH) - no Street consensus
Affimed (Nasdaq: AFMD) - consensus loss $0.23
Alamos Gold (NYSE: AGI) - no Street consensus
Aldeyra Therapeutics (Nasdaq: ALDX) - consensus loss $0.44
American Shared Hospital (NYSE:... More